Dr. Morcillo is the director of internal medicine Hospital Cima Sanitas in Barcelona and the medical director of Sanitas digital hospital. He is an active advocate and user of digital technologies in his daily practice. He will join the HIMSS & Health 2.0 European conference in September as an expert in the session on digital therapeutics.
The below Q&A has been edited for length and...
Less than a week after FDA opened the faucet for digital health products treating psychiatric conditions during the COVID-19 health crisis, Akili has fast-tracked and released its approval-pending digital therapeutic for children with ADHD.
Now known as Endeavor and flanked by a symptom tracker and caretaker support line, the video game-like app will be provided at no cost for a limited time to...
Digital oncological therapeutics company Kaiku Health has developed a symptom monitoring system for patients with coronavirus to be used by Geneva University Hospitals (HUG). The platform will assist HUG in triaging patients who suspect they have the virus or who have already been diagnosed, both in and out of hospital.
WHAT IT DOES
Each day patients will fill out a digital report of their...
Easy access to (temporarily) free counseling. Consumer telehealth and mail-order prescription services Hims and Hers are dipping into the mental health wellness space. The brands kicked off new anonymized group therapy and guided meditation offerings yesterday, with the therapy sessions led by a licensed mental health practitioner.
The group sessions are currently being offered free of charge in...
Nordic startup SideKickHealth is working with the COVID-19 response team in Iceland to provide its digital therapeutics platform to people who have been diagnosed with the virus.
Its platform allows the remote triaging and managing of large numbers of people in isolation, who self-report on a panel of symptoms and measurements via a smartphone app multiple times a day.
Patients are assessed via...
Pear Therapeutics announced this morning that Somryst, its prescription digital therapeutic for adults with chronic insomnia, has received marketing authorization from the FDA.
The treatment provides cognitive behavioral therapy for insomnia (CBTi) alongside personalized, algorithm-generated sleep restriction recommendations. The digital therapeutic was reviewed through the agency's 510(k)...
A CVS Health service designed to help CVS Caremark pharmacy benefit management clients more easily roll out and manage third-party health products has added five new digital health offerings to its lineup.
The program – which has also seen a branding change from "Vendor Benefit Management" to "Point Solutions Management" – was first announced last June with only single participating vendor: Big...
A full transcript of STARS-ADHD — the pivotal trial of Akili Interactive’s video game-like pediatric attention deficit treatment — has been published in The Lancet Digital Health journal, providing onlookers a clear view of data fueling the digital therapeutic company’s pending FDA submission.
The writeup echoes topline findings first unveiled by the company in December 2017: compared to a...
Editor's note: The original version of this story claimed that STARS-ADHD Adjunctive enrolled 2016 subjects, instead of 206. We apologize for this error.
Digital therapeutic company Akili Interactive has announced the first results of an open-label, multisite pediatric ADHD trial providing some patients with the company’s video game-like treatment alongside a stimulant medication.
Called the ...
Following news of hardships at Proteus Digital Health, CEO Andrew Thompson has told STAT News that the company is winding down its high-profile $88 million deal with Otsuka Pharmaceutical, and will be pivoting from its current primary focus on mental disorders toward cancers and infectious disease treatments.
The pharmaceutical company has now acquired the full license for Proteus’ mental health...
